Fairvalue-Calculator Fairvalue-Calculator
EN DE

Aroa Biosurgery Limited (AROAF) Fair Value & Analysis

Healthcare · US · Market cap $180M

Price$0.5200
Fair Value$0.5000
Upside-3.8%
Quality89/100
Evidence: Low Range $0.3800 – $0.6300

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Aroa Biosurgery Limited (AROAF) currently trades at $0.5200, while our model-based Fair Value estimate is $0.5000 — implying the stock looks roughly 3.8% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine that delivers a bolus of biologically important ECM proteins to help kick start and sustain healing; and Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company also develops products for abdominal wall reconstruction, hernia repair, and breast reconstruction in North America and Europe. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, Ne…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Aroa Biosurgery Limited (AROAF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.5000 versus a price of $0.5200 — about −4% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AROAF?
Our 21-model fair value for Aroa Biosurgery Limited is $0.5000 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.5200.
What is the quality score of AROAF?
Aroa Biosurgery Limited has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.